Bruno Vellas - Concepedia

Author

Bruno Vellas

Also Known As

A. Hodges, Angela Hodges, B Vellas, B. J. Vellas, B. VELLAS, B. Vellas, B.J Vellas, B.J. Vellas, BRUNO J. VELLAS, Bertrand Fougère

1.2K

Publications

102.5K

Citations

135

H-Index

281

Concepts

All Affiliations

Inserm Université Fédérale de Toulouse Midi-Pyrénées Université Toulouse III - Paul Sabatier Centre Hospitalier Universitaire de Toulouse King's College London

About

Bruno Vellas is an author at Inserm specializing in medicine, geriatrics, and dementia.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	40	73	6.6K
2	Engineering	2	2	161
3	Business	1	1	59
4	Education	1	1	29
5	Management	1	1	59

Bruno Vellas

517

Publications

70.7K

Citations

115

H-Index

Page 1

	Year	Citations
Lecanemab in Early Alzheimer’s Disease Christopher H. van Dyck, Chad J. Swanson, Paul Aisen, New England Journal of Medicine	2022	4.7K
Frailty Consensus: A Call to Action John E. Morley, Bruno Vellas, Gabor Abellán van Kan, Journal of the American Medical Directors Association Frailty ConsensusGeriatricsLongevityFrailtyMedicine	2013	4K
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria Bruno Dubois, Howard Feldman, Claudia Jacova, The Lancet Neurology NeuropsychologyAlzheimer's DiseaseDementiaResearch Diagnostic CriteriaBiomarkers	2014	3.2K
Screening for Undernutrition in Geriatric Practice: Developing the Short-Form Mini-Nutritional Assessment (MNA-SF) Laurence Z. Rubenstein, Judith O. Harker, Antoni Salvà, The Journals of Gerontology Series A	2001	2.6K
Validation of the Mini Nutritional Assessment short-form (MNA®-SF): A practical tool for identification of nutritional status Matthias Kaiser, Jürgen M. Bauer, C. Rämsch, The journal of nutrition health & aging ObesityNutritionPractical ToolBody CompositionNutritional Requirement	2009	1.9K
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, New England Journal of Medicine	2014	1.6K
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease Samantha Budd Haeberlein, Paul Aisen, Frederik Barkhof, The Journal of Prevention of Alzheimer s Disease	2022	1.2K
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease Rachelle S. Doody, Rema Raman, Martin R. Farlow, New England Journal of Medicine	2013	1.2K
Sarcopenia With Limited Mobility: An International Consensus John E. Morley, Angela Marie Abbatecola, Josep M. Argilés, Journal of the American Medical Directors Association Global HealthInternational ConsensusInternational HealthDisease OutbreakAnatomy	2011	1.1K
International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines Míkel Izquierdo, Reshma Aziz Merchant, John E. Morley, The journal of nutrition health & aging Physical ActivityExercise MedicineKinesiologyHealthy AgingExercise	2021	1.1K

Page 1